Rankings
▼
Calendar
NTLA Q3 2016 Earnings — Intellia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
NTLA
Intellia Therapeutics, Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
-$3M
-61.4% margin
Operating Income
-$8M
-158.1% margin
Net Income
-$7M
-153.7% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
+15.8%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$301M
Total Liabilities
$83M
Stockholders' Equity
$218M
Cash & Equivalents
$291M
← FY 2016
All Quarters
Q4 2016 →
